Paos Industries (530291)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue momentum: sales grew 36.11%, and latest quarter sales of ₹25 Cr show the business is still active and expanding.
• Low sales-based entry: market cap of ₹24 Cr against quarterly sales of ₹25 Cr leaves scope for high operating leverage if margins recover.
• Reported ROE of 25.26% hints at past efficiency on equity, although current ROCE of -1.35% warrants caution.

Concerns

• Current unprofitability: latest quarter net loss of ₹1 Cr and profit growth of -1181.82% destroy earnings credibility.
• Weak capital returns: ROCE at -1.35% and Piotroski F-Score of 3/9 point to poor financial health.
• Lack of disclosure: book value, debt/equity, and promoter holding are not available, reducing analytical confidence.
• Margin of safety absent: price ₹38.43 is below the stated 52-week low, no dividend, and edible oil is a commoditized business without a durable moat.

AI Analysis

Here we have a tiny edible-oil player, and the numbers do not excite me. In my world, a business must first earn a respectable return on capital before I care about growth. Paos Industries shows 36.11% sales growth, but that growth seems to be destroying value: profit growth is -1181.82%, and the latest quarter delivered ₹25 crore of sales yet a net loss of ₹1 crore. The reported ROE of 25.26% catches the eye, but with ROCE at -1.35% and no book value or debt-equity ratio disclosed, I cannot trust that headline figure. The P/E is meaningless with negative earnings. Graham taught us to rely on facts, not hope. The market cap is only ₹24 crore, and the stock trades at ₹38.43, below the stated 52-week range of ₹45.66 to ₹60.10, which tells me the market is repricing something. With a Piotroski F-Score of 3/9, the financial health looks poor. Edible oil is a commodity business with limited pricing power; I do not see a durable moat. A low price-to-sales ratio is not automatically a bargain—if sales growth consumes capital and still produces losses, the cheap valuation can become cheaper. There is no dividend to compensate. This looks like a cyclical business in a down cycle; perhaps a turnaround attempt, but I see no margin of safety. I would want strong evidence of margin recovery, positive free cash flow, and honest disclosure of book value and debt before investing a rupee. Until then, this is a pass. In investing, avoiding losses matters more than chasing growth.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer